Ethinamate - PharmaKB

Ethinamate

Valmid (ethinamate) is a small molecule pharmaceutical. Ethinamate was first approved as Valmid on 1982-01-01. It is used to treat sleep initiation and maintenance disorders in the USA.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

Therapeutic Area	MeSH
nervous system diseases	D009422
mental disorders	D001523

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Ethinamate

Tradename	Company	Number	Date	Products
VALMID	Dista Products	N-009750 DISCN	1982-01-01	1 products

Hide discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

Indication	Ontology	MeSH	ICD-10
sleep initiation and maintenance disorders	—	D007319	F51.01

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

No data

HCPCS

No data

Clinical

No data

Drug

General

Drug common name	Ethinamate
INN	ethinamate
Description	Ethinamate is a carbamate ester that is the 1-vinylcyclohexyl ester of carbamic acid. A short-acting sedative-hypnotic, it was formerly used to treat insomnia. It has a role as a sedative. It is a carbamate ester and a terminal acetylenic compound.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	C#CC1(OC(N)=O)CCCCC1